Shareholders in Inspire Medical Systems, Inc. (NYSE:INSP) had a terrible week, as shares crashed 31% to US$174 in the week since its latest first-quarter results. Revenues of US$164m arrived in line with expectations, although statutory losses per share were US$0.34, an impressive 50% smaller than what broker models predicted. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
See our latest analysis for Inspire Medical Systems
Taking into account the latest results, the consensus forecast from Inspire Medical Systems’ 17 analysts is for revenues of US$787.7m in 2024. This reflects a solid 19% improvement in revenue compared to the last 12 months….
